「so」の検索結果
138件：26～30件目を表示
-
要 該当しない II．名称に関する項目 －3－ II．名称に関する項目 1．販売名 （1）和名 ミケランLA点眼液1％ ミケランLA点眼液2％ （2）洋名 Mikelan LA ophthalmic solution 1％・2％ （3）名称の由来 ミケラン LA 点眼液 1％・2％の LA は Long Acting の略である。 2．一般名 （1）和名（命名法） カルテオロール塩酸塩（JAN） ...
https://www.senju.co.jp/system/files/2022-03/20220330_MKLA_IF.PDF -
an unstable tear film causing discomfort and/or visual impairment, accompanied by ocular surface disorder” *. Recently, the number of DED patients has been increasing due to an aging population, the ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
an unstable tear film causing discomfort and/or visual impairment, accompanied by ocular surface disorder” *. Recently, the number of DED patients has been increasing due to an aging population, the ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
Production | About Senju | SENJU Pharmaceutical
re created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as injections, pharmaceutical technique st...
http://www.senju.co.jp/english/about/production.html -
Overseas Activities | SENJU Pharmaceutical
nacego Daszynskiego 2B,Warsaw, Poland Postal Code：00-843 Tel：+48-22-236-0505 Fax：+48-22-236-0506 SLOSOregon, USA OTRADI Bioscience Incubator, 4640 S Macadam Ave., Suite 200C, Portland, OR 97239, U.S.A...
http://www.senju.co.jp/english/global/